Evergreening: How Pharmaceutical Brands Delay Generic Drugs with Patent Tactics
Evergreening lets drug companies extend patents on old medications through minor changes, blocking generics and keeping prices high. Learn how tactics like product hopping and patent thickets delay affordable alternatives-and what’s being done to stop it.
Read Details
